Where TennCare Falls Short: Closing the Gaps in Substance Use Disorder Treatment in Tennessee

“It’s very easy to get into recovery, and very difficult to stay in recovery,” said Mark Lasko, Executive Director of Samaritan Recovery Community in Nashville. Patients leave treatment with 30 days of sobriety and a plan to continue care. But within days, that plan falls apart. Follow-up treatment is often delayed while providers wait for insurance approval, and continuation of care must be repeatedly justified and may be denied if it fails to meet the definition of “medical necessity.” When decisions are appealed, the process can take weeks or even months, leaving patients without care at the most vulnerable point in recovery.
Why “Eliminating Drug Use” Isn’t Enough
A recent report by the Tennessee Department of Health’s State Unintentional Drug Overdose Reporting System (SUDORS) documented a staggering 16,182 overdose deaths from 2019 to 2023. These deaths aren’t just statistics. They are lives of families, coworkers, classmates, and neighbors being impacted by alcohol, stimulants, opioids, and polysubstance use. Although it’s easy to say we should eliminate drug use altogether, that mindset does little to help the thousands of people already facing addiction. The National Institute on Drug Abuse defines addiction as a brain disorder because it involves changes to brain circuits responsible for reward, stress, and self-control that can persist long after a person has stopped using. Furthermore, studies estimate that 40 to 60 percent of people treated for substance use disorder relapse, a rate comparable to chronic illnesses such as hypertension and asthma. Recovery requires a healthcare system capable of supporting people through the long and often uneven process of healing.
Coverage vs Access
TennCare covers substance use disorder treatment and plays a central role in financing behavioral health care for Tennesseans. However, coverage doesn’t mean treatment actually happens. Before treatment even begins, providers must submit detailed prior authorization requests that include a patient’s substance use history, mental health status, and living conditions. Approval is often granted for only a short period, sometimes as little as one week, and providers must repeatedly explain to insurance companies why the patient still requires that level of care. This reauthorization process not only creates delays but also increases the likelihood of denials based on how “medical necessity” is interpreted. Patients may be denied because their substance use is not considered recent enough, their primary substance is deemed less severe or because they aren’t immediately at risk of withdrawal, to name a few. When coverage is denied, the appeals process can take 60 days or more, leaving patients without consistent treatment during a critical period. In response, treatment centers like Samaritan Recovery Community are forced to bear the financial burden and continue providing care while fighting these decisions.
Other States Show Policy Matters
Virginia’s Medicaid Addiction and Recovery Treatment Services reform expanded levels of care to include outpatient and residential treatment programs, reduced prior authorization and other legal barriers, and strengthened care coordination across providers. Following these changes, the number of Medicaid members receiving substance use disorder treatment increased by 57 percent, and opioid related emergency department visits fell by 25 percent. Similar effects appeared when administrative barriers were removed throughout the US. Across 23 states, eliminating prior authorization requirements for buprenorphine, a key medication for opioid use disorder, led to a 40 percent increase in prescribing. Medicare plans that dropped these requirements saw about twice as many prescriptions written, along with fewer hospital visits related to substance use disorder (SUD). These outcomes demonstrate that when barriers are reduced and care is easier to access, patients are more likely to seek treatment.
The Policy Choice in Front of Tennessee
If Tennessee wants to reduce overdose deaths, TennCare policy must reflect the reality that substance use disorder is chronic and recovery depends on continuity of care.
First, patients should not have to rely on weekly re-approvals to remain in treatment. TennCare should extend the length of time initial prior authorization covers and remove requirements for crucial medications like buprenorphine, which are proven to reduce overdose and relapse risk.
Second, the current definition of medical necessity focuses on recent substance use or withdrawal symptoms, which fail to cover patients leaving prison or transitioning between levels of care. Policy should require insurance companies to consider not only relapse risk and treatment history but also clinical judgment so that patients aren’t denied simply because they aren’t currently in a crisis.
Finally, TennCare must ensure continuity of care during appeal processes. Although coverage may continue during appeals in some cases, the process often fails to protect patients at critical points in care, and appeals that take 60 days or more can significantly burden the treatment centers.
While TennCare has made meaningful progress in expanding access to SUD treatment, too many patients still fall through gaps in care, and closing those gaps must be Tennessee’s next priority. As Johann Hari writes, “the opposite of addiction is not sobriety. It’s connection.” When care is denied or delayed, patients are left to fight their hardest battles alone.



